RESUMO
Cutaneous diseases of the ear encompass a wide range of symptoms, complaints, and factors that negatively impact patients' well-being. These observations are frequently encountered by otolaryngologists and other physicians who treat individuals with ear-related issues. In this document, we aim to offer up-to-date information on diagnosing, predicting outcomes, and treating commonly occurring ear diseases.
Assuntos
Otopatias , Orelha Externa , Humanos , Otopatias/diagnóstico , Otopatias/terapiaAssuntos
Biópsia/estatística & dados numéricos , Pacientes Internados/estatística & dados numéricos , Encaminhamento e Consulta/tendências , Pele/patologia , Telemedicina/instrumentação , Biópsia/métodos , COVID-19/diagnóstico , COVID-19/epidemiologia , COVID-19/patologia , COVID-19/virologia , Currículo/tendências , Dermatologia/educação , Dermatologia/métodos , Diagnóstico Diferencial , Feminino , Humanos , Internato e Residência/estatística & dados numéricos , Masculino , Patologia/educação , Patologia/métodos , Melhoria de Qualidade , Estudos Retrospectivos , SARS-CoV-2/genética , Inquéritos e Questionários , Interface Usuário-ComputadorRESUMO
Antimelanoma differentiation-associated gene 5 dermatomyositis (anti-MDA5 DM) is an amyopathic subtype of DM that presents with the classic cutaneous findings of DM, such as a heliotrope rash, Gottron papules, and the shawl sign, combined with mucocutaneous ulcerations. This subtype of DM also is highly associated with rapidly progressive interstitial lung disease (ILD). We report 2 cases of a heretofore novel presentation of the overlap of these cutaneous features in the form of an ulcerative heliotrope rash; furthermore, the rash was associated with progression of ILD in both cases. Finally, we review the current state of clinical care and research related to anti-MDA5 DM in terms of clinical presentations, diagnostic methods, and treatment options.